Column Expansion

News Center > Press Release

Application for clinical trial of QX005N injection was accepted by NMPA

来源：This site 日期：2020-04-10
The application for clinical trial of innovative drug QX005N injection was officially accepted by the national medical products administration on April 9, 2020, with the acceptance number CXSL20000066.
上一条：Qyuns Therapeutics finished series B round funding
下一条：Results of phase I clinical of QX001S

WeChat

WeChat

About Us Therapeutic Areas Tec&Pro News Center Careers Contact Us

    • Address: B304 Vaccine Engineering Center, No.28 Xinglin Road, Taizhou, Jiangsu, China.

    • Tel: 0523-82386502

    • Beijing Office: Room 3206, Building 4, Wanda Plaza, Chaoyang District, Beijing.

      Tel: 010-58208565

    • E-mail：qyuns@qyuns.net

分享到：

Copyright ? 2019 Qyuns Therapeutics Co., Ltd. All Rights Reserved. Designed by Wanhu